TxCell announces its financial calendar for 2015

Posted: 30 January 2015 | TxCell

TxCell SA announces its financial calendar for 2015…

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today its financial calendar for 2015. 

February 4, 2015: Publication of full year 2014 revenues (after market)

April 1, 2015: Publication of 2014 annual results (after market)

May 6, 2015: Publication of Q1 2015 revenues (after market)

May 26, 2015: Annual shareholders’ meeting

August 4, 2015: Publication of Q2 2015 revenues (after market)

September 22, 2015: Publication of H1 2015 results (after market)

November 5, 2015: Publication of Q3 2015 revenues (after market)

In addition to these updates, investors can consult the website of the company ( where information is regularly updated. All corporate and financial information on the company is available on the company’s website, in the Finance section.

Related organisations